POST Online Media Lite Edition



 

'Mono' virus linked to 7 serious diseases

Staff Writer |
A far-reaching study conducted by scientists at Cincinnati Children's reports that the Epstein-Barr virus (EBV) - best known for causing mononucleosis - also increases the risks for some people of developing seven other major diseases.

Article continues below




Those diseases are: systemic lupus erythematosus (SLE), multiple sclerosis (MS), rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), inflammatory bowel disease (IBD), celiac disease, and type 1 diabetes.

Combined, these seven diseases affect nearly 8 million people in the U.S.

Study results published April 12 in the journal Nature Genetics. The project was led by three scientists: John Harley, MD, PhD, Director of the Center for Autoimmune Genomics and Etiology (CAGE) at Cincinnati Children's and a faculty member of the Cincinnati VA Medical Center; Leah Kottyan, PhD, an immunobiology expert with CAGE; and Matthew Weirauch, PhD, a computational biologist with the center.

Critical contributions were provided by Xiaoting Chen, PhD, and Mario Pujato, PhD, both also in CAGE.

The study shows that a protein produced by the Epstein-Barr virus, called EBNA2, binds to multiple locations along the human genome that are associated with these seven diseases.

Overall, the study sheds new light on how environmental factors, such as viral or bacterial infections, poor diet, pollution or other hazardous exposures, can interact with the human genetic blueprint and have disease-influencing consequences.

"Now, using genomic methods that were not available 10 years ago, it appears that components made by the virus interact with human DNA in the places where the genetic risk of disease is increased," Harley says. "And not just for lupus, but all these other diseases, too."

The full impact of this study could take years to explore. Here are some of the initial implications:

EBV is a strikingly common virus. In the US and other developed nations, more than 90 percent of the population becomes infected by age 20. In less-developed nations, 90 percent of people become infected by age 2. Once infected, the virus remains in people for their entire lives.

Mononucleosis, which causes weeks of extreme fatigue, is the most common illness caused by EBV. Mono was nicknamed the "kissing disease" years ago because the virus spreads primarily via contact with saliva.

Over the years, scientists have linked EBV to a few other rare conditions, including certain cancers of the lymphatic system. Harley, who has devoted much of his career to studying lupus, found possible connections between lupus and EBV years ago.

That work includes proposing mechanisms that the immune system uses in response to the virus that lead to lupus, and showing that children with lupus almost always are infected with EBV.

Today's study adds weight to those lupus findings and adds six more well-known diseases to the list.

"This discovery is probably fundamental enough that it will spur many other scientists around the world to reconsider this virus in these disorders," Harley says.

"As a consequence, and assuming that others can replicate our findings, that could lead to therapies, ways of prevention, and ways of anticipating disease that don't now exist." So far, no vaccine exists that will prevent EBV infection.

"I think we've come up with a really strong rationale for encouraging people to come up with more of an effort," Kottyan says. "Some EBV vaccines are under development. I think this study might well encourage them to push forward faster and with rededicated effort."

When viral and bacterial infections strike, our bodies respond by commanding B cells within our immune systems to crank out antibodies to battle the invaders. However, when EBV infections occur, something unusual happens.

The EBV virus invades the B cells themselves, re-programs them, and takes over control of their functions.

The Cincinnati Children's research team has discovered a new clue about how the virus does this, a process that involves tiny proteins called transcription factors.

Our bodies have about 1,600 known transcription factors at work within our genome. Each cell uses a subset of these to become what they are and to respond to their environment.

These proteins constantly move along the strands of our DNA, turning specific genes on and off to make sure cells function as expected.

However, when the transcription factors change what they do, the normal functions of the cell can also change, and that can lead to disease.

The Cincinnati Children's team suspects that the EBNA2 transcription factor from EBV is helping change how infected B cells operate, and how the body responds to those infected cells.

The new paper shows that seven seemingly unrelated disease states actually share a common set of abnormal transcription factors, each affected by the EBNA2 protein from the Epstein-Barr virus.

When these EBNA2-related clusters of transcription factors attach themselves to one portion of the genetic code, the risk of lupus appears to rise. When those same transcription factors land on another part of the code, the risk of multiple sclerosis appears to rise. And so on.

"Normally, we think of the transcription factors that regulate human gene expression as being human," Kottyan says.

"But in this case, when this virus infects cells, the virus makes its own transcription factors, and those sit on the human genome at lupus risk variants (and at the variants for other diseases) and that's what we suspect is increasing risk for the disease."

It remains unclear how many cases of the seven diseases listed in the study can be traced to prior EBV infection. More genomic analyses involving many more patients with these diseases will be required to make reliable estimates.

"The impact of the virus is likely to vary across the diseases," Harley says. "In lupus and MS, for example, the virus could account for a large percentage of those cases. We do not have a sense of the proportion in which the virus could be important in the other EBNA2-associated diseases."

However, the breakthrough identification of specific transcription factors connected to EBV infections opens new lines of study that could accelerate efforts to find cures.

"This same cast of characters is a villain in multiple immune-related diseases," Weirauch says.

"They're playing that role through different ways, and doing it at different places in your genome, but it's the same sinister characters. So if we could develop therapies to stop them from doing this, then it would help multiple diseases."

A number of compounds - some experimental, some approved as medications for other conditions - already are known to be capable of blocking some of the high-risk transcription factors listed in the paper, Weirauch says. Teams at Cincinnati Children's have begun deeper studies of some of these compounds.

While the EBV-related findings involved more than 60 human proteins linked to seven diseases, the Cincinnati Children's research team already has taken a huge next step.

They applied the same analytic techniques to tease out connections between all 1,600 known transcription factors and the known gene variants associated with more than 200 diseases.

The results of that massive cross-analysis also appear in today's study. Intriguing associations were documented involving 94 conditions.

"Our study has uncovered potential leads for many other diseases, including breast cancer," Harley says. "We cannot possibly follow up on all of these, but we are hoping that other scientists will."

After devoting decades of research to hunting down the causes of lupus, Harley says this study represents the most important discovery of his career.

"I've been a co-author in almost 500 papers. This one is more important than all of the rest put together. It is a capstone to a career in medical research," he says.

Detecting and tracking the activities of these transcription factors took years of work involving dozens of laboratory and computational experts.

The project required gathering massive sets of genetic data, then analyzing every genetic change affecting the activity of the virus.

Doing this required creating two new algorithms, called RELI and MARIO, which were developed at Cincinnati Children's by Weirauch and colleagues.

Both software tools and a related website will be made publicly available.


What to read next

Ebola virus adapts itself to kill humans more effectively
Ebola virus could reproduce in lungs of recovering patient
Promising treatment for deadly respiratory virus

U.S.: Heavy snowfall through weekend

 
Meteorological winter is off to a fast start across much of the Northwest, Great Basin, and Rockies as plentiful moisture streams inland from the Pacific Ocean over at least the next few days.
 
 

Latest

U.S. oil rig count climbs by 5 to 505
Over 2,300 trucks waiting to cross into EU from Belarus, line keeps growing
Rode NT1 5th Generation, the ultimate studio microphone
Slovakia to extend grain embargo, expand list of banned agricultural products from Ukraine

NEWS

Storm Babet package of support coming in Scotland

566 arrests in week of coordinated actions in Southern Europe
Somalia receives 25,000 tons of grain from Russia as humanitarian aid
U.S.: Severe thunderstorms across southeast Texas
New York holiday toy, coat and school supply drive to start on Friday
North Carolina: Following Governor’s advocacy, EPA reverses approval of plan to import Chemours waste
 

BUSINESS

New report highlights promise of Lithium Valley in California

Greece’s new FSRU to receive first LNG cargo in January
Cayman Islands to build new submarine cable
Spain inaugurates high speed rail from Madrid to Asturias
Zimbabwe commissions Chinese company's lithium processing plants
Bulgaria plagued by shortage of medical professionals
 

Trending Now

Dai Nippon Printing will create 352 new jobs in Davidson County, North Carolina

Equinor sells Nigerian business and Agbami oil field stake to Chappal Energies

Commission bans Fly Baghdad from flying in European Union

Slovakia to extend grain embargo, expand list of banned agricultural products from Ukraine


POLITICS

Brazil to join OPEC+ in 2024

Zimbabwe mulls wealth tax targeting rich
138 new jobs coming to West Michigan
New York: $100 million for zero-emission school buses
Poland to seek return of EU permits for Ukrainian haulers
EU Solidarity Fund grants €100 million of advance payment to Slovenia following summer floods
 

Today We Recommend

Good decision for China: U.S. judge blocks Montana's ban of TikTok


Highlights 

Emmi opens new cheese conversion facility in U.S.

Dai Nippon Printing will create 352 new jobs in Davidson County, North Carolina

AbbVie buys Immunogen for $10 billion


COMPANIES

Emmi opens new cheese conversion facility in U.S.

Commission sends Statement of Objections in automotive starter battery cartel case
Commission bans Fly Baghdad from flying in European Union
Mercedes and BMW to establish joint high power charging network in China
Good decision for China: U.S. judge blocks Montana's ban of TikTok
Dai Nippon Printing will create 352 new jobs in Davidson County, North Carolina
 

CAREERS

Pyxis Oncology appoints Ken Kobayashi as chief medical officer

Amylyx Pharmaceuticals appoints Camille L. Bedrosian as chief medical officer
Federal Signal Corporation appoints Katrina L. Helmkamp to board
First Resource Bancorp appoints Kristen Fries as CFO
Network International appoints Mpho Sadiki as group managing director, merchant solutions for Africa
Liquid Intelligent Technologies: Oswald Jumira new CEO of Liquid C2 business unit
 

ECONOMY

Canadian GDP declines in Q3

Finland's economy contracts in Q3
Italy's annual inflation rate lowest in 32 months
Fitch upgrades Pennsylvania’s credit rating from ‘AA-’ to ‘AA
U.S. weekly jobless claims inch up to 218,000
U.S. Q3 GDP growth revised up to annual rate of 5.2 pct
 

EARNINGS

Dell Technologies revenue $22.3 billion

American Outdoor Brands Q2 sales $57.9 million
Marvell Technology Q3 revenue $1.419 billion
BMO Financial Q4 income $1,617 million
Cracker Barrel Old Country Store profit $5.46 million
Kroger Q3 earnings to $646 million
 

OP-ED

Micromanaging is the worst enemy of efficiency and teamwork

Niger set to monetize massive gas reserves through Saharan natural gas pipeline
Putting the brakes on EV folly that choked the market
Oil discovery in Kavango Basin may mean huge benefits for Namibians
Cape Town and Dubai battle over Africa's energy future
Is America going to lose its superpower status?
 

AGRIFISH

Commission approves €500 million French State aid scheme to support investments in agriculture

Georgia refused entry to 21.5 tons of Belarusian potatoes
Value of cereal production in EU €64.4 billion, milk value €58.0 billion
Rosselkhoznadzor begins inspections of Brazilian poultry meat producers
Kazakhstan will supply peaches, cherries, and plums to China
Poland to start exporting apples to Indonesia
 

LEADERSHIP

LinkedIn can trigger feelings of imposter syndrome

Study suggests corporate culture thwarts efforts to hire innovative candidates
Workplace wellness policies could soften effects of workaholism
Customers willing to wait longer for delivery when they shop in store showroom
Internal crowdfunding fosters innovation and engages employees
Employee owned businesses deliver an 8 to 12% productivity boost
 

CRIME

BNP Paribas subsidiary fined maximum amount over Swiss franc loans

Commission fines Rabobank €26.6 million over Euro-denominated bonds trading cartel
Shell Energy fined £1.4m by Ofcom for consumer protection breaches
Italy's antitrust agency fines energy companies for aggressive billing
New Jersey duo defrauded investors and mortgage lenders through $2.5 million investment scam
SEC charges Royal Bank of Canada with internal accounting controls violations
 

Magazine

TRAVEL

Mushrooms of all kinds will be featured at Autumn Bio Festival in Portugal

Festive winter fun in and around Hannover
Premier Australian motoring event returns this weekend
Yummy cake and bake show in London with great prizes
Tuileries Garden Christmas, magic of Christmas in Paris
Museum of the Moon to welcome all science fans in Larnaca
 

SEA, LAND, AIR

Chevrolet Tahoe and Suburban come with new look

Chinese HiPhi revealed electric sedan, too bad it can't be trusted
New 2025 Ram 1500, Hurricane 3L and 420 horsepower
Gulfstream G700 business jet to fly 14,353 kilometers
Beneteau First, slender mainsail and generously sized foresails
Porsche launches speedboat with 400 kW
 

DESIGN

Hollywood Regency, the style that's always in

Filippo Loreti, premium Italian timepieces for adventurous gentlemen
Creative furniture that redefines the meaning of sofa
Perfect ovens for perfect pizza at home
Designer radiators, focal point that heats your room
What to do and what not to do when designing your living room
 

GADGETS

Motorola g family smartphones bring something for everyone

Focal Shape 65 monitor, loudspeakers for home or professional studio
NAD C 268 stereo power amplifier, multipurpose workhorse
DeVore Fidelity Orangutan O/Reference, €90,000 for ultimate sound
Motorola razr, foldable phone that allows you to live your real life
Rogers 65V-1 integrated amplifier delivers remarkable sound made in America
 

HEALTH

Pathogens use force to breach immune defenses

Governor Moore announces expanded access to contraceptive care across Maryland
California Governor Newsom announces new legislation to prevent illicit use and trafficking of xylazine
Argentina records hundreds of Trichinella cases
Loss of auditory nerve fibers uncovered in individuals with tinnitus
Netherlands sees alarming surge in pneumonia among children, China disinfecting schools
 

MEANTIME

Artificial intelligence used to detect plastic waste at sea

Astronomers spot giant stream of stars between galaxies
Six exoplanets discovered in synchronised dance
Earth braces for geomagnetic storm on November 30 after two powerful solar flares
Frozen food temperatures changed by just three degrees to save CO2 emissions
Groundbreaking method to match celestial objects across telescopes